Active substance
Torasemide
- SFDA 6
- US FDA 17
- US price lines 4
- NHS prices 2
- WHO EML 2
- Safety 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| EXAMIDE | 5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 23.45 | Generic · Prescription | Apex Pharma | Valid |
| EXAMIDE | 10 mg | Film-coated tablet · Oral use | 30 Blister | SAR 39.75 | Generic · Prescription | Apex Pharma | Valid |
| EXAMIDE | 20 mg | Film-coated tablet · Oral use | 20 Blister | SAR 66.10 | Generic · Prescription | Apex Pharma | Valid |
| Exetora 20 mg/4 ml | 5 mg/ml | Solution for injection · Intravenous use | 5 Ampoule | SAR 84.00 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| UNAT 10MG TAB | 10 mg | Tablet · Oral use | 30 Blister | SAR 39.75 | NCE · Prescription | ROCHE DIAGNOSTICS | Withdrawn by MAH · Not Marketed |
| UNAT 5MG TAB | 5 mg | Tablet · Oral use | 30 Blister | SAR 23.45 | NCE · Prescription | ROCHE DIAGNOSTICS | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE KIDNEY INJURY (AKI); CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; HYPERKALEMIA; PULMONARY ARTERIAL HYPERTENSION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | PLIVA PHARM IND | Prescription | 30 May 2003 |
| TORSEMIDE | 20MG | tablet · oral | HIKMA PHARMS | Prescription | 1 Mar 2005 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | COREPHARMA | Prescription | 31 May 2005 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | AUROBINDO PHARMA | Prescription | 17 Oct 2007 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | HETERO LABS LTD III | Prescription | 27 Jan 2009 |
| SOAANZ | 40MG | tablet · oral | SARFE PHARMS | Prescription | 14 Jun 2021 |
| TORSEMIDE | 5MG; 10MG; 20MG | tablet · oral | MICRO LABS | Prescription | 1 May 2026 |
| DEMADEX | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | PHARMOBEDIENT | Discontinued | 23 Aug 1993 |
| DEMADEX | 20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · intravenous | ROCHE | Discontinued | 23 Aug 1993 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | TEVA | Discontinued | 14 May 2002 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 27 May 2003 |
| TORSEMIDE | 5MG; 10MG | tablet · oral | HIKMA PHARMS | Discontinued | 1 Mar 2005 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | SUN PHARM INDS | Discontinued | 26 Feb 2008 |
| TORSEMIDE | 20MG/2ML (10MG/ML); 50MG/5ML (10MG/ML) | solution · intravenous | HIKMA | Discontinued | 11 Jun 2008 |
| TORSEMIDE | 20MG/2ML (10MG/ML); 50MG/5ML (10MG/ML) | solution · intravenous | AM REGENT | Discontinued | 21 Apr 2010 |
| TORSEMIDE | 5MG; 10MG; 20MG; 100MG | tablet · oral | STRIDES PHARMA INTL | Discontinued | 22 Mar 2011 |
| SOAANZ | 20MG; 60MG | tablet · oral | SARFE PHARMS | Discontinued | 14 Jun 2021 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | TORSEMIDE 10 MG TABLET | $0.06594 | per EA | 23 Sep 2026 |
| US NADAC | TORSEMIDE 100 MG TABLET | $0.17384 | per EA | 23 Sep 2026 |
| US NADAC | TORSEMIDE 20 MG TABLET | $0.06361 | per EA | 23 Sep 2026 |
| US NADAC | TORSEMIDE 5 MG TABLET | $0.05726 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Torasemide 10mg tablets | £13.69 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Torasemide 5mg tablets | £16.51 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 16. Diuretics · core
Therapeutic equivalent to furosemide for Anuria or oliguria; Therapeutic equivalent to furosemide for Oedema - 12.4. Medicines used in heart failure · core
Therapeutic equivalent to furosemide for Heart failure
Safety signals and safety-related labeling changes
- US FDA 3 Feb 2017 DEMADEX — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.